A37. ILD THERAPY I

查看最新文献

A37. ILD THERAPY I - 最新文献

Does HRCT Pattern Influence the Effect of Nintedanib in Patients with Progressive Fibrosing Interstitial Lung Diseases?

Pub Date : 2020-05-01 DOI: 10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a1507 K. Brown, S. Walsh, A. Devaraj, Jin Woo Song, W. Wuyts, C. Valenzuela, R. Goeldner, S. Stowasser, R. Schlenker‐Herceg, A. Wells

Effect of Nintedanib in Patients with Limited and Extensive Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD): Data from the SENSCIS Trial

Pub Date : 2020-05-01 DOI: 10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a1525 N. Goh, C. Denton, D. Lynch, T. Maher, V. Smith, A. Prasse, V. Cottin, R. Spiera, C. Stock, M. Gahlemann, M. Alves, A. Wells

A Multicenter Retrospective Observational Study on Polish Experience of Pirfenidone Therapy in Patients with Idiopathic Pulmonary Fibrosis: A Preliminary Report of PolExPIR Study

Pub Date : 2020-05-01 DOI: 10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a1513 S. Majewski, A. Białas, Paweł Gomółka, K. Górska, E. Jassem, A. Kania, R. Krenke, J. Kuś, K. Lewandowska, M. Martusewicz-Boros, K. Roszkowski-Sliz, A. Siemińska, K. Sładek, M. Sobiecka, M. Tomczak, W. Tomkowski, E. Wiatr, B. Żołnowska, W. Piotrowski

查看全部

免责声明：
本页显示期刊或杂志信息，仅供参考学习，不是任何期刊杂志官网，不涉及出版事务，特此申明。如需出版一切事务需要用户自己向出版商联系核实。若本页展示内容有任何问题，请联系我们，邮箱：info@booksci.cn，我们会认真核实处理。